Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
DESCRIPTION: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for diabetes in asymptomatic adults. METHODS: The USPSTF reviewed the evidence on screening for impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes in asymptomatic, nonpregnant adults who are at average or high risk for diabetes and its complications. POPULATION: This recommendation applies to adults aged 40 to 70 years seen in primary care settings who do not have symptoms of diabetes and are overweight or obese. RECOMMENDATION: The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity. (B recommendation).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intensive Behavioral Counseling (IBC) interventions like the National Diabetes Prevention Program (NDPP), have demonstrated effectiveness in reducing excess body weight and lowering or delaying morbidity onset.”
In the citing paper
“Intensive Behavioral Counseling (IBC) has been widely accepted as an effective approach for compliant individuals to reduce body weight, improve clinical measures, and lower risk of obesity-related comorbidities [1–6].”
In the citing paper
“The US Preventive Services Task Force (USPSTF) recommends that, as part of cardiovascular diseases (CVD) risk assessment, all overweight and obese adults between age 40 and 70 be screened for abnormal blood glucose, and those with CVD risk factors (e.g., hypertension, dyslipidemia, prediabetes) be referred for IBC, such as programs modeled on the National Diabetes Prevention Program (NDPP) [3,5].”
In the citing paper
“All individuals met the USPSTF criteria for receiving IBC because they had CVD risk factors independent of excess body weight; with 997 (89%) also meeting the CDC and NDPP recommendations for intervention due to prediabetes [3,5,17].”
In the citing paper
“Previous work has found that IBC intervention, including NDPP, among overweight and obese adults with prediabetes and CVD risk factors can improve clinical measures, prevent or delay disease onset, reduce medical expenditures, and increase productivity (in the form of higher labor force participation and lower work absenteeism) [1–6,13–15,19].”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“The Diabetes Prevention Program (11), conducted in the United States in 3234 participants, found that an intensive lifestyle modification intervention was associated with better quality of life at 3-year follow-up.”
BackgroundStandards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465 · cited 1×
“Similarly, the Steno-2 Study (31) showed a reduction in all-cause mortality (RR, 0.”
BackgroundEffects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
Li, G., Zhang, P., Wang, J., Gregg, E. W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60766-7 · Cited by 1,600 · cited 3×
“One Finnish (12) and 1 Chinese (13) trial, each with more than 500 participants, suggested improvements in all-cause mortality outcomes after 10 and 20 years, respectively (HR, 0.”
BackgroundInfluential
Research works printed but not linked: 3
- Mortaz S, 2012, Clinicoecon Outcomes Res, 4, 91
- Hemmingsen B, 2013, Cochrane Database Syst Rev, 11, CD008143
- American Diabetes Association, 2015, Diabetes Care, 38, S1
Cited by
Items 101–200 of 321
Matson-Koffman, D. M., Robinson, S. J., Jakhmola, P., Fochtmann, L. J., Willett, D. L., Lubin, I. M., Burton, M. M., Tailor, A., Pitts, D. L., Casey, D. E., et al. (2023) · American Journal of Medical Quality · doi:10.1097/jmq.0000000000000137 · Cited by 26
Ackermann, R. T., Kang, R., Cooper, A. J., Liss, D. T., Holmes, A. M., Moran, M., & Saha, C. (2019) · Diabetes Care · doi:10.2337/dc18-2071 · Cited by 22
Predicting Risk of Type 2 Diabetes by Using Data on Easy-to-Measure Risk Factors
Turi, K. N., Büchner, D. M., & Grigsby‐Toussaint, D. S. (2017) · Preventing Chronic Disease · doi:10.5888/pcd14.160244 · Cited by 27
Nutrition, metabolic syndrome, and obesity: Guidelines for the care of people with spina bifida
McPherson, A. C., Chen, L., O’Neil, J., & Vanderbom, K. A. (2020) · Journal of Pediatric Rehabilitation Medicine · doi:10.3233/prm-200753 · Cited by 26
The risk of diabetes after giving birth to a macrosomic infant: data from the NHANES cohort
Miller, C., & Lim, E. (2021) · Maternal Health, Neonatology and Perinatology · doi:10.1186/s40748-021-00132-8 · Cited by 21
“Services Task Force (USPSTF) only mentions screening those affected by GDM and not those with an macrosomic infant alone [26], as does the American College of Obstetricians and Gynecologists (ACOG), who recommend screening women with GDM for type 2 diabetes or impaired glucose tolerance 6–12 weeks postpartum and then…”
MethodPredictors of undiagnosed prevalent type 2 diabetes – The Danish General Suburban Population Study
Heltberg, A., Andersen, J. S., Sandholdt, H., Siersma, V., Kragstrup, J., & Ellervik, C. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.08.005 · Cited by 25
Revisiting the Global Overfat Pandemic
Maffetone, P. B., & Laursen, P. B. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00051 · Cited by 25
Treatment of Patients with Prediabetes in a Primary Care Setting 2011–2018: an Observational Study
Speaker, S. L., Rastogi, R., Sussman, T. A., Hu, B., Misra‐Hebert, A. D., & Rothberg, M. B. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06354-4 · Cited by 24
“Since 2014, the US Preventive Task Force (USPTF) has recommended intervention for prediabetes, and longitudinal measurement of MNT use is needed to estimate implementation.(8,9) In a recent survey of physicians, 67% reported recommending MNT to at least some patients,(10) and national visit-level data indicate that di…”
MethodAlbu, J., Sohler, N., Li, R., Li, X., Young, E., Gregg, E. W., & Ross‐Degnan, D. (2017) · Diabetes Care · doi:10.2337/dc16-2133 · Cited by 24
Jiranek, W. A., Kigera, J. W. M., Klatt, B. A., Küçükdurmaz, F., Lieberman, J. R., Moser, C. E., Mulhall, K. J., Nahouli, H., Schwarz, E. M., Shohat, N., et al. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.09.052 · Cited by 23
Framework for Using Risk Stratification to Improve Clinical Preventive Service Guidelines
Lin, J. S., Evans, C. V., Grossman, D. C., Tseng, C., & Krist, A. H. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.07.023 · Cited by 22
The State of Diabetes Prevention Policy in the USA Following the Affordable Care Act
Konchak, J. N., Moran, M. R., O’Brien, M. J., Kandula, N. R., & Ackermann, R. T. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0742-6 · Cited by 26
Prediabetes: Screening, Diagnosis, and Intervention
Watson, C. (2017) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2016.08.005 · Cited by 26
Versorgungs-Report Früherkennung
Günster, C., Klauber, J., Robra, B.-P., Schmacke, N., Schmuker, C., & KG, M. M. W. V. M. &. C. (2019) · Medizinisch Wissenschaftliche Verlagsgesellschaft eBooks · doi:10.32745/9783954664542 · Cited by 29
Yuan, Y., Xie, H., Sun, L., Wang, B., Zhang, L., Han, H., Yao, R., Sun, Y., & Fu, L. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s238224 · Cited by 19
“6 mmol/L was defined as impaired fasting glucose (IFG).(25,26)”
BackgroundAli, M. K., Imperatore, G., Benoit, S. R., O’Brien, M. J., Holliday, C. S., Echouffo-Tcheugui, J. B., & Bullard, K. M. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110572 · Cited by 26
Cost‐effectiveness of diabetes screening initiated through a dental visit
Neidell, M., Lamster, I. B., & Shearer, B. S. (2017) · Community Dentistry And Oral Epidemiology · doi:10.1111/cdoe.12286 · Cited by 27
Hemoglobin A1c levels and risk of sudden cardiac death: A nested case-control study
Patel, R. B., Moorthy, M. V., Chiuve, S. E., Pradhan, A. D., Cook, N. R., & Albert, C. M. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.08.044 · Cited by 19
Palladino, R., Vamos, E. P., Chang, K., Khunti, K., Majeed, A., & Millett, C. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-58033-3 · Cited by 20
Kashbour, M. O., Abdelmalik, A., Yassin, M. N. A., Abed, M., Aldieb, E., Abdullah, D. M., Elmozugi, T., Isawi, Y. S., Hassan, E., & Almuzghi, F. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01619-6 · Cited by 27
“DM research has led to advancements in screening, diagnosis, and treatment [7–11].”
Primary Care Cluster RCT to Increase Diabetes Prevention Program Referrals
Keck, J. W., Roper, K. L., Hieronymus, L. B., Thomas, A. R., Huang, Z., Westgate, P. M., Fowlkes, J. L., & Cardarelli, R. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.02.008 · Cited by 20
Hulbert, L. R., Zhang, X., Ng, B. P., Nhim, K., Khan, T., & Cannon, M. J. (2021) · American Journal of Health Promotion · doi:10.1177/08901171211044937 · Cited by 18
Scanlan, A. B., Maia, C. M., Perez, A., Homko, C. J., & O’Brien, M. J. (2017) · Diabetes Spectrum · doi:10.2337/ds16-0051 · Cited by 19
“Preventive Services Task Force recommended dysglycemia screening among adults who are 40–70 years of age and overweight or obese (30).”
MethodIncidence of diabetes after a partner's diagnosis
Cunningham, S. A., Adams, S. R., Schmittdiel, J. A., & Ali, M. K. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.08.020 · Cited by 20
“(2015; Siu, 2015) These guidelines focus on established individual diabetes risk factors such as age, weight, and family history.”
Kelly, J. F., Greene, M. C., Abry, A., & Bergman, B. G. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108493 · Cited by 17
“Consequently, screening, early detection, and treatment programs have been developed for a number of physical health conditions (Chatterjee et al., 2017; Siu, 2015).”
BackgroundSecondary prevention of diabetes through workplace health screening
Bali, V., Yermilov, I., Koyama, A. K., & Legorreta, A. P. (2018) · Occupational Medicine · doi:10.1093/occmed/kqy138 · Cited by 15
Chevet, B., Figueroa‐Parra, G., Yang, J. X., Hocaoǧlu, M., Osei‐Onomah, S., Hulshizer, C. A., Gunderson, T. M., Cornec, D., Barbour, K. E., Greenlund, K. J., et al. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02878-8 · Cited by 18
“Diabetes mellitus screening was evaluated with the measurement of blood glucose; the recommended interval was every 3 years [37].”
MethodOn behalf of the NEXT-D Study Group, Ali, M. K., Wharam, J. F., Duru, O. K., Schmittdiel, J. A., Ackermann, R. T., Albu, J., Ross‐Degnan, D., Hunter, C. M., Mangione, C. M., et al. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1112-3 · Cited by 16
Catov, J. M., Sun, B., Bertolet, M., Snyder, G. G., Lewis, C. E., Allen, N. B., Shikany, J. M., Ingram, K. H., Appiah, D., & Gunderson, E. P. (2020) · Obesity · doi:10.1002/oby.22848 · Cited by 15
Arefin, A., & Gage, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054785 · Cited by 17
“Type-2 Diabetes Mellitus (T2DM) is a complex, chronic illness characterized by persistent high blood glucose levels (Siu 2015).”
BackgroundGlucoScreen: A Smartphone-based Readerless Glucose Test Strip for Prediabetes Screening
Waghmare, A., Parizi, F. S., Hoffman, J. S., Wang, Y., Thompson, M. J., & Patel, S. (2023) · Proceedings of the ACM on Interactive Mobile Wearable and Ubiquitous Technologies · doi:10.1145/3580855 · Cited by 16
Diabetes Prevention in a U.S. Healthcare System: A Portrait of Missed Opportunities
Mainous, A. G., Rooks, B. J., Wright, R. U., Sumfest, J. M., & Carek, P. J. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.06.018 · Cited by 17
Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes
Roy, S. S., & Demmer, R. T. (2021) · Translational research · doi:10.1016/j.trsl.2021.11.002 · Cited by 17
“The current systematic review identified consistent, reproducible associations but several limitations were observed including: (1) a consistent lack of robust confounder adjustment for risk factors collected prior to infection; (2) lack of data on insulin resistance or glycemia measures [Hemoglobin A1c (HbA1c) or glu…”
Updated clinical guidelines experience major reporting limitations
Vernooij, R. W. M., García, L. M., Flórez, I. D., Armas, L. H., Poorthuis, M. H. F., Brouwers, M. C., & Alonso‐Coello, P. (2017) · Implementation Science · doi:10.1186/s13012-017-0651-3 · Cited by 16
O’Brien, M. J., Bullard, K. M., Zhang, Y., Gregg, E. W., Carnethon, M. R., Kandula, N. R., & Ackermann, R. T. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4436-4 · Cited by 20
Leveraging EHRs for patient engagement: perspectives on tailored program outreach.
Brown, S. D., Grijalva, C., & Ferrara, A. M. (2017) · PubMed · Cited by 15
Tuberculosis Screening, Testing, and Treatment of US Health Care Personnel
Thanassi, W. T., Behrman, A. J., Reves, R. R., Russi, M. B., Swift, M. D., Warkentin, J. V., Miyakawa, R., Wegener, D. H., Budnick, L. D., Murray, E., et al. (2020) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001904 · Cited by 14
“and the US Preventive Services Task Force recommends screening adults for diabetes.(46) Given the high risk of progression to active TB disease in patients with untreated comorbidities, this TB evaluation presents a logical opportunity to recommend diabetes and HIV screening if not previously done.”
BackgroundRodríguez, L. A., Bradshaw, P. T., SHIBOSKI, S. C., Fernández, A., Vittinghoff, E., Herrington, D. M., Ding, J., & Kanaya, A. M. (2020) · Diabetic Medicine · doi:10.1111/dme.14377 · Cited by 15
Lee, J., Kim, K. H., Ahn, J. C., Kim, J. A., Lee, G., Son, J. S., Choi, S. J., Oh, Y. H., & Park, S. M. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002268 · Cited by 16
Nguyen, B., Lin, K. W., & Mishori, R. (2018) · Public health reviews · doi:10.1186/s40985-018-0095-6 · Cited by 16
Soler, R. E., Proia, K. K., Jackson, M. C., Lanza, A., Klein, C., Leifer, J., & Darling, M. (2018) · Diabetes Spectrum · doi:10.2337/ds18-0022 · Cited by 17
Kim, J., Yang, H.-L., Kim, S. H., Kim, S., Lee, J., Ryu, J., Kim, K., Kim, Z., Ahn, G., Kwon, D., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102445 · Cited by 17
Postmenopausal women in gynecological care
Pertyńska−Marczewska, M., & Pertyński, T. (2021) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2021.107103 · Cited by 20
Thomas, T., Golin, C. E., Samuel‐Hodge, C. D., Kirkman, M. S., Golden, S. D., & Lightfoot, A. F. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106587 · Cited by 14
Kent, D. M., Nelson, J., Pittas, A. G., Colangelo, F. R., Koenig, C., Klaveren, D. V., Ciemins, E. L., & Cuddeback, J. K. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2021.09.012 · Cited by 12
Chen, C., Liu, L., Huang, J., Yu, Y., Lo, K. K.-H., Huang, Y., & Feng, Y. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s260990 · Cited by 12
Buccheri, E., Dell’Aquila, D., & Russo, M. (2022) · Obesity Medicine · doi:10.1016/j.obmed.2022.100398 · Cited by 15
Preventive Health for Transgender Men and Women
Graf, E., McCune, K. C., & Imborek, K. L. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1604457 · Cited by 18
Nontargeted Diabetes Screening in a Navajo Nation Emergency Department
Anderson, E. S., Dworkis, D. A., DeFries, T., Emery, E., Deegala, C., & Mohs, K. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304799 · Cited by 13
Brunisholz, K. D., Conroy, M. B., Belnap, T. W., Joy, E. A., & Srivastava, R. (2020) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000281 · Cited by 12
“Preventive Services Task Force Guidelines Measures In 2015, the USPSTF recommended two evidencebased diabetes prevention guidelines as follows: (1) screening at-risk patients and (2) referring individuals with prediabetes to intensive behavioral counseling intervention.(4) Both guidelines were aGradeB evidence level i…”
MethodGinting, J. B., Suci, T., Ginting, C. N., & Girsang, E. (2023) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_33_23 · Cited by 17
Schmidt, T. J., Aviña-Zubieta, J. A., Sayre, E. C., Abrahamowicz, M., Esdaile, J. M., & Lacaille, D. V. (2018) · The Journal of Rheumatology · doi:10.3899/jrheum.170973 · Cited by 11
Glenn, B. A., Nonzee, N. J., Hamilton, A. S., Tieu, L., Maxwell, A. E., Crespi, C. M., Chang, L. C., Deapen, D., & Bastani, R. (2020) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00925-4 · Cited by 11
National Asthma Education and Prevention Program 2020 Guidelines: What’s Important for Primary Care
Murphy, M. (2021) · The Journal of Family Practice · doi:10.12788/jfp.0219 · Cited by 16
Xie, S., Monteiro, K., & Gjelsvik, A. (2022) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06792-x · Cited by 12
Multilevel Variation in Diabetes Screening Within an Integrated Health System
Obinwa, U., Pérez, A., Lingvay, I., Meneghini, L., Halm, E. A., & Bowen, M. E. (2020) · Diabetes Care · doi:10.2337/dc19-1622 · Cited by 13
Family Involvement to Stop the Conversion of Prediabetes to Diabetes
Prakoso, D. A., Mahendradhata, Y., & Istiono, W. (2023) · Korean Journal of Family Medicine · doi:10.4082/kjfm.23.0019 · Cited by 11
Prevalence of Testing for Diabetes Among US Adults With Overweight or Obesity, 2016–2019
Chen, Y., Lundeen, E. A., Koyama, A. K., Kompaniyets, L., Andes, L. J., Benoit, S. R., Imperatore, G., & Rolka, D. B. (2023) · Preventing Chronic Disease · doi:10.5888/pcd20.230173 · Cited by 14
Azzam, A. Y., Medina, L., Morsy, M. M., Essibayi, M. A., Altschul, D., & Nassar, M. (2025) · ASIDE Internal Medicine · doi:10.71079/aside.im.02202517 · Cited by 17
Vettoretti, M., Longato, E., Zandonà, A., Li, Y., Pagán, J. A., Siscovick, D. S., Carnethon, M. R., Bertoni, A. G., Facchinetti, A., & Camillo, B. D. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001223 · Cited by 11
Reproducibility of Glycemic Measures Among Dysglycemic Youth and Adults in the RISE Study
Tjaden, A. H., Edelstein, S. L., Arslanian, S. A., Barengolts, E., Caprio, S., Cree‐Green, M., Lteif, A. A., Mather, K. J., Savoye, M., Xiang, A. H., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad135 · Cited by 9
Rhee, M. K., Safo, S. E., Jackson, S. L., Xue, W., Olson, D. E., Long, Q., Barb, D., HAW, J. S., Tomolo, A. M., & Phillips, L. S. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.09.021 · Cited by 10
Slack, D. J., & Safer, J. D. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.11.001 · Cited by 12
Collaborative Modeling: Experience of the U.S. Preventive Services Task Force
Petitti, D. B., Lin, J. S., Owens, D. K., Croswell, J. M., & Feuer, E. J. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.07.003 · Cited by 10
Optimizing diabetes screening frequencies for at-risk groups
Wu, C.-C., & Suen, S. (2021) · Health Care Management Science · doi:10.1007/s10729-021-09575-z · Cited by 17
Moya, A., Freese, J., & Bracke, P. (2023) · Social Science & Medicine · doi:10.1016/j.socscimed.2023.116262 · Cited by 10
Brateanu, A., Barwacz, T., Kou, L., Wang, S., Misra‐Hebert, A. D., Hu, B., Deshpande, A., Kobaivanova, N., & Rothberg, M. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187695 · Cited by 9
The Importance of Prediabetes Screening in the Prevention of Cardiovascular Disease
Ćosić, V., Jakab, J., Praveček, M. K., & Miškić, B. (2023) · Medical Archives · doi:10.5455/medarh.2023.77.97-104 · Cited by 13
Rogers, M. A. M., & Kim, C. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12957 · Cited by 12
“Screening for gestational diabetes and screening for type 2 diabetes in adults is currently recommended, but there is insufficient evidence for childhood diabetes screening in high risk groups.(14,15) Our results suggest that screening in populations at high risk of diabetes, such as those with congenital rubella synd…”
BackgroundKirley, K., Khan, T., Aquino, G. C., Brown, A. R., Meier, S., Chambers, N. A., & O’Connell, C. (2021) · JAMIA Open · doi:10.1093/jamiaopen/ooab101 · Cited by 10
Matsushita, K., Tang, O., & Selvin, E. (2019) · JAMA · doi:10.1001/jama.2019.19428 · Cited by 10
Gregg, E. W., & Moin, T. (2021) · JAMA · doi:10.1001/jama.2021.12559 · Cited by 9
Thomas, T., Golin, C. E., Kinlaw, A. C., Kirkman, M. S., Golden, S. D., Lightfoot, A. F., & Samuel‐Hodge, C. D. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06749-x · Cited by 7
“moderate to strong data indicating that a substantial proportion of diabetes cases can be delayed or prevented if addressed in the prediabetes stage.(6)”
BackgroundInfluentialTozivepi, S. N., Takawira, S., Chikaka, E., Mundagowa, P. T., Chadambuka, E. M., & Mukora-Mutseyekwa, F. (2021) · Patient Preference and Adherence · doi:10.2147/ppa.s306885 · Cited by 12
“Empirical evidence also reported that hypertension is associated with type 2 diabetes mellitus, thus diabetic screening is recommended in all people living with hypertension.(7) The risk of CVDs and the associated burden of the health system could be reduced through the prevention, control, and treatment of hypertensi…”
BackgroundDiabetes screening intervals based on risk stratification
Ohde, S., McFadden, E. C., Deshpande, G. A., Yokomichi, H., Takahashi, O., Fukui, T., Perera, R., & Yamagata, Z. (2016) · BMC Endocrine Disorders · doi:10.1186/s12902-016-0139-1 · Cited by 8
“While existing guidelines [7, 10] do mention screening intervals, these have been typically based on a combination of previous studies [15, 16] and expert opinion, none of which have fully considered risk as a criteria for screening.”
BackgroundDetection and Management of Diabetes in England: Results from the Health Survey for England
Xiao, M., & O’Neill, C. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0300-5 · Cited by 9
O’Brien, M. J., & Sacks, D. B. (2019) · JAMA · doi:10.1001/jama.2019.14063 · Cited by 8
Study protocol: Using peer support to aid in prevention and treatment in prediabetes (UPSTART)
Heisler, M., Kullgren, J. T., Richardson, C. R., STOLL, S. C., Nieves, C. A., Wiley, D. M., Sedgwick, T., Adams, A. S., Hedderson, M. M., Kim, E. S., et al. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.106048 · Cited by 9
Early arteriosclerosis and its risk factors in subjects with prediabetes and new-onset diabetes
Liu, X., Liu, L., Wang, R., Jia, X., Liu, B., Ma, N., & Lü, Q. (2021) · Endocrine Connections · doi:10.1530/ec-21-0202 · Cited by 9
Disparities in the Use of Diabetes Screening in Appalachia
Lobo, J. M., Anderson, R. T., Stukenborg, G. J., McCall, A. L., Kang, H., Camacho, F., & Sohn, M. (2017) · The Journal of Rural Health · doi:10.1111/jrh.12247 · Cited by 9
Chou, M.-Y., Huang, S., Liang, C., Hsiao, F., & Chen, L. (2020) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2020.104039 · Cited by 9
Cao, Q., Zheng, R., He, R., Wang, T., Xu, M., Lu, J., Dai, M., Zhang, D., Chen, Y., Zhao, Z., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155238 · Cited by 11
Stakeholder Analysis: Medicare Diabetes Prevention Program Awareness and Implementation
Turk, M. T., Ritchie, N. D., & Jakub, K. (2023) · The American Journal of Managed Care · doi:10.37765/ajmc.2023.89372 · Cited by 9
PREVENTIONAL SCREENING: ALL PROS AND CONTRAS
Вачиковна, П. Н., Yufereva, Y. M., Samorodskaya, I. V., & Boytsov, S. A. (2016) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2016-3-4-13 · Cited by 7
Primary Prevention of CVD with Aspirin: Benefits vs Risks
Weisman (2021) · The Journal of Family Practice · doi:10.12788/jfp.0222 · Cited by 9
Bhatt, R., Ingle, S. M., Sackpraseuth, A., Venkatraman, S., Sharp, N., Chung, S., Long, J., Palaniappan, L. P., & Srinivasan, M. (2021) · Journal of Asian Health · doi:10.59448/jah.v1i1.4 · Cited by 7
DESAI, J. R., Saman, D. M., Sperl‐Hillen, J. M., Pratt, R. J., Dehmer, S. P., Allen, C. I., Ohnsorg, K. A., Wuorio, A., Appana, D., Hitz, P. J., et al. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106686 · Cited by 9
Lukic, I., Ranković, N., Savić, N., Ranković, D., Popov, Ž., Vujic, A., & Folic, N. (2022) · Healthcare · doi:10.3390/healthcare10050921 · Cited by 5
Stephenson-Hunter, C., Pacheco, G., Kim, R. S., Gao, Q., Hosgood, H. D., & Chambers, E. C. (2023) · Preventing Chronic Disease · doi:10.5888/pcd20.230072 · Cited by 6
Low-Cost Chipless RFID Glucose Sensor for Diabetes Screening
García-Cardarelli, P., Villa-González, F., Vinacua, M., Paredes, J., Valderas, D., & Bhattacharyya, R. (2023) · Proceedings of IEEE Sensors/Proceedings of IEEE Sensors ... · doi:10.1109/sensors56945.2023.10325238 · Cited by 6
“Even if the existing commercial quick blood-sugar strips used with glucometers are easy to use and provide on-the-spot readings, they only become affordable for routine device users already diagnosed with diabetes [8].”
BackgroundGlycemic deviation index: a novel method of integrating glycemic numerical value and variability
Zou, Y., Wang, W., Zheng, D., & Hou, X. H. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00691-z · Cited by 6
Glurich, I., Berg, R. L., Panny, A., Shimpi, N. A., Steinmetz, A., Nycz, G. R., & Acharya, A. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.670355 · Cited by 8
“Whereas, current US Preventive Services Task Force (USPSTF) guidelines recommends screening for type 2 DM (T2DM) for individuals with hypertension, aged 40–70 years who meet obesity status definitions [6], glycemic screening in the dental setting has remained controversial (reviewed by Glurich et al.”
BackgroundComprehensive Geriatric Assessment
Dharmarajan, T. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_8 · Cited by 8
Medical Family Therapy in Family Medicine
Hodgson, J. L., Trump, L. J., Wilson, G., & Garcia‐Huidobro, D. (2018) · Focused issues in family therapy · doi:10.1007/978-3-319-68834-3_2 · Cited by 7
Green, M. B., Shimbo, D., Schwartz, J. E., Bress, A. P., King, J. B., Muntner, P., Sheppard, J. P., McManus, R. J., Kohli-Lynch, C. N., Zhang, Y., et al. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac071 · Cited by 7
Sorkin, D. H., Rook, K. S., Campos, B., Marquez, B., Solares, J., Mukamel, D. B., Marcus, B. H., Kilgore, D. B., Dow, E., Ngo‐Metzger, Q., et al. (2018) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.03.013 · Cited by 6
Screening for Dysglycemia: Connecting Supply and Demand to Slow Growth in Diabetes Incidence
Ali, M. K., & Narayan, K. M. V. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002084 · Cited by 7
“The recent expansion of criteria for dysglycemia screening, to adults aged 40–70 years who are overweight or obese, by the USPSTF is a welcome step [13].”
BackgroundBowen, M. E., Merchant, Z., Abdullah, K., Bhat, D., Fish, J., & Halm, E. A. (2017) · Health Services Research and Managerial Epidemiology · doi:10.1177/2333392817721647 · Cited by 6
Kissane, L. M., Meyer, I., Martin, K. D., Tan, J. C., Miller, K., & Richter, H. E. (2018) · Neurourology and Urodynamics · doi:10.1002/nau.23803 · Cited by 6
Diabetes Prediction Using Machine Learning Approaches
Dutta, S., & Bandyopadhyay, S. K. (2021) · Lecture notes on data engineering and communications technologies · doi:10.1007/978-981-16-0538-3_9 · Cited by 6
Metadata
- Authors
- Siu, A. L., & on behalf of the U.S. Preventive Services Task Force*
- Affiliations
- United States Preventive Services Task Force (US)
- Corresponding author
- Siu, Albert L.
- ORCID
- Siu, Albert L.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2015-12-01
- Volume
- 163
- Issue
- 11
- Pages
- 861-868
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2184512969
- Semantic Scholar
- d2283e77e36b23e882188941e6140255c0dc9669
- Cited by
- 319
- References
- 49
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 16 · 2023: 30 · 2022: 16 · 2021: 56 · 2020: 40 · 2019: 27 · 2018: 39 · 2017: 42 · 2016: 32 · 2015: 1
- FWCI
- 40.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, diabetes screening, impaired fasting glucose, impaired glucose tolerance, abnormal blood glucose, asymptomatic adults, overweight and obesity, cardiovascular risk assessment, behavioral counseling, primary care
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Mass Screening, Middle Aged, Cost of Illness, Risk Assessment, Glucose Metabolism Disorders, Asymptomatic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.